Mechanism underlying the reduced positive inotropic effects of the phosphodiesterase III inhibitors pimobendan, adibendan and saterinone in failing as compared to nonfailing human cardiac muscle preparations
暂无分享,去创建一个
W. Schmitz | A. Haverich | H. Leyen | H. Scholz | J. Neumann | B. Stein | U. Mende | J. Starbatty | M. Nose | W. Meyer | V. Döring | H. Wenzlaff | Peter Kalmir | Holger Wenzlaff